Symposium on Neuroimaging in Alcoholism

描述（由申请人提供）：这第二次会议致力于酒精中毒的神经成像将是另一个开创性的事件，吸引成像研究人员对酒精中毒的研究，希望推进对这种疾病的认识。在大脑成像的其他领域工作的既定研究人员以及那些已经在酗酒相关领域工作的研究人员将被召集起来，分享酗酒的方法应用，并促进跨模式的合作。将作出特别努力，支持研究学员、研究员和新调查员的出席和参与。该计划将平行于2004年举行的非常成功的第一次ICANA会议，包括一个为期两天半的研讨会的国际发言者名单。观众预计将包括来自世界各地的150-200名研究人员。建议的会议日期为2008年1月18日至21日。 拟议议程将包括6个主要议题和一个海报会议： 磁共振成像（MRI）和扩散张量成像（DTI） 功能性磁共振成像（fMRI） 磁共振波谱（MRS） o使用正电子发射断层扫描（PET）和单光子发射计算机断层扫描（SPECT）的神经受体成像 o分子成像/基因表达，动物光学成像 遗传和临床前景 会议将包括全体演讲和会议，致力于每种成像方式（MRI-DTI，fMRI，MRS，PET-SPECT），以及与分子遗传学，动物和人类神经成像的联系，以及神经成像在酒精依赖治疗研究中的应用。

DESCRIPTION (provided by applicant): This second conference devoted to neuroimaging in alcoholism will be another seminal event in drawing imaging researchers toward research on alcoholism in hopes of advancing knowledge about this disorder. Established investigators who work in other areas of brain imaging as well as those already working in alcoholism-related areas will be convened to share methodological applications to alcoholism and foster collaboration across modalities. Special efforts will be made to support the attendance and participation of research trainees, fellows, and new investigators. The program will parallel the highly successful 1Pst ICANA conference held in 2004 by including an international roster of speakers in a two and a half-day symposium. The audience is expected to include 150-200 researchers from around the world. The proposed meeting dates are January 18-21-, 2008. The proposed agenda will include 6 main topics and a poster session: o Magnetic resonance imaging (MRI) & Diffusion tensor imaging (DTI) o Functional magnetic resonance imaging (fMRI) o Magnetic resonance spectroscopy (MRS) o Neuroreceptor imaging using Positron emission tomography (PET) & Single photon emission computed tomography (SPECT) o Molecular imaging/gene expression, Optical imaging in animals o Genetic and Clinical Perspectives The conference will include plenary presentations and sessions dedicated to each modality of imaging (MRI-DTI , fMRI, MRS, PET-SPECT), as well as links to molecular genetics, neuroimaging in animals and humans, and applications of neuroimaging to the study of the treatment of alcohol dependence.